First Horizon Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History
First Horizon Advisors, Inc.
- $3.53 Billion
- Q1 2025
A detailed history of First Horizon Advisors, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 59 shares of COLL stock, worth $1,639. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 26
126.92%
Holding current value
$1,639
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding COLL
# of Institutions
245Shares Held
35.4MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$161 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$73.3 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$65.3 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$63.4 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.78MShares$49.3 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $948M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...